Broadspire Announces Prosthetic Partnership with HomeCare Connect
MIAMI--(BUSINESS WIRE)-- Broadspire, a Crawford Company, has chosen HomeCare Connect as its preferred partner for prosthetics and custom orthotics. The partnership will provide highly specialized care management services for injured workers who have undergone amputations.
“We appreciate the specialized care and cost containment this partnership brings to our clients and the injured workers we advocate for,” said Erica Fichter, Broadspire’s SVP of Medical Management. “Our mission of restoring lives, businesses and communities is something we live every day and this partnership will bring it to life for those who need it most.”
Early intervention, expert clinical guidance and empathetic communication drive the prosthetics and custom orthotics program, which:
- Conducts a lifestyle assessment
- Identifies qualified providers
- Provides clinical, peer-to-peer counseling
- Helps select prosthetics
- Oversees care through the life of the claim
- Provides prospective and retrospective bill review
“This high-touch, clinically driven approach ensures injured workers receive the most appropriate care and prostheses at fair and reasonable costs,” said HomeCare Connect’s CEO Teresa Williams.
About HomeCare Connect
Specializing in catastrophic cases, HomeCare Connect focuses exclusively on managing the quality and cost of home health, durable medical equipment and supplies for workers’ compensation payers. With more than 17,000 directly contracted network providers, services include home health, DME, and home modification along with prosthetics and orthotics. HomeCare Connect’s partners consolidated their 20-plus years of workers’ compensation experience into offerings and service standards that ensure that injured workers receive excellent care in the fastest time frames at the most affordable prices. Based near Orlando, the privately held company serves clients nationally and can be reached at www.homecareconnect.com or 855-223-2228.
About Broadspire
Based in Atlanta, Crawford & Company (NYSE: CRD‐A and CRD‐B) is the world’s largest publicly listed independent provider of claims management and outsourcing solutions to insurance companies and self‐insured entities with an expansive global network serving clients in more than 70 countries. The Company’s two classes of stock are substantially identical, except with respect to voting rights and the Company’s ability to pay greater cash dividends on the non-voting Class A Common Stock (CRD-A) than on the voting Class B Common Stock (CRD-B), subject to certain limitations. In addition, with respect to mergers or similar transactions, holders of CRD-A must receive the same type and amount of consideration as holders of CRD-B, unless different consideration is approved by the holders of 75 percent of CRD-A, voting as a class. More information is available at www.crawco.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190722005018/en/
For HomeCare Connect
Helen King Patterson, APR
King Knight Communication
813-690-4787
[email protected]
Source: HomeCare Connect
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crawford & Company Board Approves Quarterly Dividends
- Rabies Diagnostics Market to Reach USD 2.68 Billion by 2030, Driven by Rising Demand for Rapid Testing and Disease Surveillance
- Spain Solar Energy Market to Reach 85.77 GW by 2031 as Solar PV Leads with 94.45% Share and Storage Trends Shift – Mordor Intelligence
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share